## Clinical Context This is a classic presentation of **Type Ia Glycogen Storage Disease (GSD Ia)** — glucose-6-phosphatase deficiency. The key findings are: - Severe fasting hypoglycemia within 3–4 hours - Hepatomegaly with excessive glycogen - Lactic acidosis (lactate cannot be converted to glucose) - Seizures from hypoglycemia ## Immediate Management Principles **Key Point:** The primary goal in acute hypoglycemia is rapid glucose restoration PLUS prevention of recurrence through frequent feeding. ### Step-by-Step Approach 1. **Acute phase (immediate):** IV dextrose bolus (0.5–1 g/kg) to raise blood glucose rapidly and prevent seizures 2. **Maintenance phase:** Continuous nasogastric feeding with uncooked cornstarch (1–2 g/kg/4–6 hours) or glucose polymers - Cornstarch provides slow, sustained glucose release via amylase digestion - Prevents fasting-induced hypoglycemia 3. **Monitoring:** Serial blood glucose, lactate, and liver function ## Why This Works in GSD Ia | Feature | Mechanism | |---------|----------| | IV dextrose | Bypasses the enzymatic block; directly raises blood glucose | | Cornstarch | Provides glucose without requiring G6Pase activity | | Frequent feeds | Prevents the 3–4 hour fasting window that triggers crisis | | Avoids fasting | Eliminates the trigger for lactic acidosis | **High-Yield:** GSD Ia patients require **frequent small meals or continuous NG feeds** (every 2–3 hours, or overnight NG feeds) to survive. This is the cornerstone of management and prevents both hypoglycemia and secondary complications (gout, renal disease, hepatic adenomas). **Clinical Pearl:** Uncooked cornstarch is preferred over cooked starch because raw starch is digested more slowly by salivary and pancreatic amylase, providing a sustained glucose release over 4–6 hours. ## Long-Term Considerations - Liver transplantation is reserved for cirrhosis, hepatic adenomas with malignant transformation, or uncontrollable metabolic derangement — not first-line - Allopurinol for hyperuricemia (gout prophylaxis) - Monitoring for renal tubular dysfunction and hepatic malignancy
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.